Publications médicales – 2024

  • Lorenzo, D ; Aguilera Munoz, L ; Vedie, AL ; Prat, F ; Dokmak, S ; Sauvanet, A & al. Mural nodules and prevalence of high-grade dysplasia in branch duct intraductal papillary mucinous neoplasm of the pancreas undergoing resection. Br J Surg. 2024;111:
  • Hammel, P ; Smith, D ; Afchain, P ; Dominguez-Tinajero, S ; Seitz, JF ; Lievre, A & al. SUNLAND: a randomized, double-blinded phase II GERCOR trial of sunitinib versus placebo and lanreotide in patients with advanced progressive midgut neuroendocrine tumors. Ther Adv Med Oncol. 2024;16:17588359241290100
  • M » »Baloula, J ; Tougeron, D ; Boilève, A ; Jeanbert, E ; Guimbaud, R ; Ben Abdelghani, M & al. Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world study. Eur J Cancer. 2024;212:115051
  • Wang, MJ ; Wang, YC ; Masson, E ; Wang, YH ; Yu, D ; Qian, YY & al. SEC16A Variants Predispose to Chronic Pancreatitis by Impairing ER-to-Golgi Transport and Inducing ER Stress. Adv Sci (Weinh). 2024;11:e2402550
  • Haviari, S ; de Tymowski, C ; Burnichon, N ; Lemogne, C ; Flamant, M ; Ruszniewski, P & al. Measuring and correcting staff variability in large-scale OSCEs. BMC Med Educ. 2024;24:817
  • Lorenzo, D ; Rebours, V. Is it time to revise criteria and treatment of type 2 autoimmune pancreatitis? United European Gastroenterol J. 2024;12:986-987
  • Salin, G ; Ouidir, N ; Hoyeau, N ; Leenhardt, R. A uncommon lesion of the ampulla of Vater. Clin Res Hepatol Gastroenterol. 2024;48:102406
  • Fraunhoffer, N ; Hammel, P ; Conroy, T ; Nicolle, R ; Bachet, JB ; Harlé, A & al. Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma. Ann Oncol. 2024;35:780-791
  • Aguilera Munoz, L ; Boros, C ; Bonvalet, F ; de Mestier, L ; Maire, F ; Lévy, P & al. Reappraising imaging features of pancreatic acinar cystic transformation: be aware of differential diagnoses. Eur Radiol. 2024;34:7650-7658
  • Riescher-Tuczkiewicz, A ; Grégory, J ; Bert, F ; Zappa, M ; Pellat, A ; Lalande, V & al. Diagnosis and treatment of bacterial peritonitis in patients with gastrointestinal cancer: an observational multicenter study. Ther Adv Med Oncol. 2024;16:17588359241258400
  • Dermine, S ; Masson, E ; Girodon-Boulandet, E ; Bienvenu, T ; Férec, C ; Lévy, P & al. Diagnostic yield of repeat genetic testing in idiopathic chronic pancreatitis. Clin Res Hepatol Gastroenterol. 2024;48:102346
  • Hedjoudje, A ; Pokossy Epée, J ; Perez-Cuadrado-Robles, E ; Alric, H ; Rivallin, P ; Vuitton, L & al. Long-term outcomes of endoscopic ultrasound-guided hepaticogastrostomy in patients with malignant biliary obstruction. United European Gastroenterol J. 2024;12:1044-1055
  • Mekkan-Bouv Hez, M ; Derbey, L ; de Mestier, L ; Lorenzo, D ; Walter, T ; Perrier, M & al. Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study. Int J Surg. 2024;110:4259-4265
  • Salin, G ; Corpechot, C ; Ouazana, S ; Dong, C ; Becq, A ; Lemoinne, S & al. Endoscopic features of low-phospholipid-associated cholelithiasis syndrome: A retrospective cohort study. Clin Res Hepatol Gastroenterol. 2024;48:102324
  • Frendi, S ; Martineau, C ; Cazier, H ; Nicolle, R ; Chassac, A ; Albuquerque, M & al. Role of the fatty pancreatic infiltration in pancreatic oncogenesis. Sci Rep. 2024;14:6582
  • Codjia, T ; Marique, L ; Aussilhou, B ; Ftériche, FS ; de Mestier, L ; Rebours, V & al. Outcome and survival were similar with laparoscopic and open pancreatectomy in 102 solid pseudopapillary neoplasms. Surg Endosc. 2024;38:2169-2179
  • Kherabi, Y ; Michoud, C ; Villageois-Tran, K ; Bert, F ; Pioche, M ; Lefort, A & al. Epidemiology, treatment and outcomes of infected pancreatic necrosis in France: a bicenter study. Infect Dis Now. 2024;54:104866
  • Jiang, L ; Qin, J ; Dai, Y ; Zhao, S ; Zhan, Q ; Cui, P & al. Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma. Nat Med. 2024;30:749-761
  • Dufayet, L ; Piot, MA ; Geoffroy, PA ; Oulès, B ; Petitjean-Brichant, C ; Peiffer-Smadja, N & al. CARECOS study: Medical students » empathy as assessed with the CARE measure by examiners versus standardized patients during a formative Objective and Structured Clinical Examination (OSCE) station. Med Teach. 2024;46:1187-1195
  • Al Mansour, L ; De Mestier, L ; Haissaguerre, M ; Afchain, P ; Hadoux, J ; Lecomte, T & al. Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by  <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network. J Nucl Med. 2024;65:258-263
  • Overbeek, KA ; Poulsen, JL ; Lanzillotta, M ; Vinge-Holmquist, O ; Macinga, P ; Demirci, AF & al. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment. Clin Gastroenterol Hepatol. 2024;22:994-1004.e10
  • Marchese, U ; Rebours, V ; Sauvanet, A ; Caron, O ; Ali, EA ; Perkins, G & al. [Hereditary and familial forms of pancreatic adenocarcinoma: Genetic determinism, patients eligible for systematic screening, screening methods and results]. Bull Cancer. 2024;111:199-212
  • Vedie, AL ; Laouali, N ; Gelot, A ; Severi, G ; Boutron-Ruault, MC ; Rebours, V. Childhood and adulthood passive and active smoking, and the ABO group as risk factors for pancreatic cancer in women. United European Gastroenterol J. 2024;12:440-450
  • Dagorno, C ; Marique, L ; Korrel, M ; de Graaf, N ; Thouny, C ; Renault, G & al. Long-term quality of life is better after laparoscopic compared to open pancreatoduodenectomy. Surg Endosc. 2024;38:769-779
  • Nicolle, R ; Bachet, JB ; Harlé, A ; Iovanna, J ; Hammel, P ; Rebours, V & al. Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial. J Clin Oncol. 2024;42:1067-1076
  • Depotte, L ; Palle, J ; Rasola, C ; Broudin, C ; Afrăsânie, VA ; Mariani, A & al. New developments and standard of care in the management of advanced gastric cancer. Clin Res Hepatol Gastroenterol. 2024;48:102245
  • Goudet, P ; Cadiot, G ; Barlier, A ; Baudin, E ; Borson-Chazot, F ; Brunaud, L & al. French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d »étude des Tumeurs Endocrines/Association Francophone de Chirurgie Endocrinienne/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1. Ann Endocrinol (Paris). 2024;85:2-19
  • Cheminel, L ; Lupu, A ; Wallenhorst, T ; Lepilliez, V ; Leblanc, S ; Albouys, J & al. Systematic Resection of the Visible Scar After Incomplete Endoscopic Resection of Rectal Neuroendocrine Tumors. Am J Gastroenterol. 2024;119:378-381
  • Kemoun, G ; Weiss, E ; El Houari, L ; Bonny, V ; Goury, A ; Caliez, O & al. Clinical features and outcomes of patients with pancreatic cancer requiring unplanned medical ICU admission: A retrospective multicenter study. Dig Liver Dis. 2024;56:514-521